Amarin Corp Plc (AMRN) News Headlines

▮ More

Date

Headline

1/7/2021 6:20:48 AM Amarin Preliminary 2020 Revenue Up Approximately 42% - Quick Facts

1/7/2021 6:07:00 AM Amarin Sees 2020 Total Net Revenue To Be About $610 Mln

12/13/2020 9:51:40 AM Amarin Presents Encouraging Efficacy & Safety Results From Pilot Study Treating COVID-19 Infected Patients With VASCEPA

11/30/2020 8:26:11 PM Amarin Files Patent Infringement Lawsuit Against Hikma

11/20/2020 5:43:59 AM Pre-market Movers In Healthcare Sector: TTNP, AMRN, MESO, OGEN, PSTV…

10/16/2020 6:27:40 AM Pre-market Movers In Healthcare Sector: RWLK, ETTX, AMRN, CEMI...

9/3/2020 1:57:48 AM AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch

8/31/2020 6:54:25 AM Pre-market Movers In Healthcare Sector: AIMT, HUGE, AMRN, EVFM, LPCN...

8/4/2020 6:37:32 AM Amarin Plans To Undertake Its Own Focused Commercial Launch Of VASCEPA In Europe

6/17/2020 1:25:36 AM AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact

6/15/2020 7:17:51 AM Amarin Presents Data From The REDUCE-IT Study

6/1/2020 7:16:34 AM Amarin To Increase Level And Breadth Of Promotion And Education Initiatives Regarding VASCEPA

5/22/2020 2:53:16 AM FDA Approves First Generic Version Of Vascepa; Amarin On Watch

4/13/2020 11:52:00 PM AMRN Chugs Along, ATHX To Initiate Pivotal COVID-19 Trial, WORX Soars 550%

4/2/2020 10:15:10 AM What's The Buzz About Amarin Corp. (AMRN)?

3/31/2020 12:03:52 AM AMRN's Vascepa Woes, AKRO Awaits Big Day, JNJ's COVID-19 Vaccine Study In Sep

1/7/2020 6:03:18 AM Amarin Reiterates 2020 Net Total Revenue Guidance At $650 Mln-$700 Mln

1/2/2020 6:05:08 AM Amarin Says VASCEPA Approved In Canada To Reduce Risk Of Cardiovascular Events

12/14/2019 3:14:45 AM Are These Biotech Companies Buyout Candidates? Deal Or No Deal?

12/13/2019 6:19:06 PM Amarin's Vascepa Gets FDA Approval For Expanded Use, Shares Up 5%